Pfizer Inc

NYSE: PFE
$22.14
+$0.10 (+0.5%)
Closing Price on April 17, 2025

PFE Stock Chart and Intraday Price

PFE Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 235 E 42ND ST, NEW YORK, NY, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 150,147.88M USD
Shares Outstanding 5,646,780,000
Pfizer Inc. is a global leader in biopharmaceuticals, offering a wide range of medicines and vaccines. The company focuses on various therapeutic areas including cardiovascular, infectious diseases, women’s health, chronic immune and inflammatory diseases, and more. Pfizer is known for its significant contributions to COVID-19 prevention and treatment with products like Comirnaty and Paxlovid. It also has a strong portfolio in biosimilars and innovative treatments across other serious health conditions. Founded in 1849 and based in New York, Pfizer collaborates with several other healthcare giants to improve global health.

PFE Articles

The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has a reputation for being the go-to choice for income-focused investors who want both quality and yield. The ETF offers a 4.14% dividend yield,...
The good news for investors seeking high-yield dividend stocks to buy right now is that there are a number of top options for investors to consider in the high-yield dividend world. Outside of much...
April is turning out to be a tumultuous month as President Trump’s sweeping tariffs on U.S. trading partners is creating chaos and confusion. The on-again, off-again nature of the import levies (a...
With trade war volatility off the charts, investors are hunting for safety in safe dividend stocks. That’s because dividend stocks can help smooth out the ride when markets drop. Plus, companies...
Yesterday’s wild rally in the stock market where $5.5 trillion in value following President Trump hitting a 90-day pause on his tariffs, exemplifies the dramatic swings investors have experienced...
These five well-known stocks were beaten down following the recent selling but will remain attractive long after the tariff selling and profit-taking are over.
Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
Some on Wall Street now advise selling any rally in U.S. markets. However, these four high-yield dividend stocks are keepers. 
The stock market has been a wild roller coaster ride for the past five years, shifting from bull market to bear and back numerous times. It was a good lesson that stocks don’t just rise in a...
Shares of cloud-based storage solutions provider Snowflake Inc. (NYSE: SNOW) have endured a difficult month, falling -12.47% alongside the broad market’s downturn. However, year-to-date, the stock...
Here are four perfect high-yield dividend stock picks for investors looking to follow the lead of the top money managers on Wall Street.
In the 2020s, there are plenty of yield-focused exchange traded funds (ETFs) to choose from, and they’re not all created equal. Two popular dividend funds in particular — the Schwab U.S. Dividend...
We’re in a somewhat unusual economic predicament right now. On one hand, inflation remains high (at least compared to the Federal Reserve’s target of 2%). On the other, inflation has been coming...
These four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a volatile 2025.
Passive income investors looking to get paid to navigate a more turbulent stock market should look to the many dividend stocks while their yields are still north of 5%. Undoubtedly, as bond yields...